Skip to search formSkip to main contentSkip to account menu

PET regimen

Known as: Platinol-Etoposide-Taxol Regimen 
A regimen consisting of cisplatin, etoposide and paclitaxel used for the treatment of extensive-stage small cell lung cancer.
National Institutes of Health

Related topics

Related topics

6 relations

Broader (2)

Antineoplastic Combined Chemotherapy ProtocolsEpirubicin
CisplatinEtoposidePaclitaxelSmall cell carcinoma of lung

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Phase II Study of the Combination of Low-Dose Thalidomide, Prednisone, and Etanercept (PET Regimen) in the Treatment of Anemia, Splenomegaly, and Constitutional Symptoms Associated with Myelofibrosis…
BACKGROUND: Disease manifestations in myelofibrosis with myeloid metaplasia (MMM) that require therapy include anemia… 
1997
1997
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung.
A 64-year-old man was diagnosed as having large cell carcinoma of lung and suffered from recurrent tumors after repeated surgical… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)